201 related articles for article (PubMed ID: 23380467)
1. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review.
Yu C; Chang C; Zhang J
J Autoimmun; 2013 Mar; 41():34-45. PubMed ID: 23380467
[TBL] [Abstract][Full Text] [Related]
2. Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 IFN in Cutaneous Lupus: An In-Depth Immunoprofile of Subacute and Discoid Lupus.
Vazquez T; Patel J; Kodali N; Diaz D; Bashir MM; Chin F; Keyes E; Sharma M; Sprow G; Grinnell M; Dan J; Werth VP
J Invest Dermatol; 2024 Jun; 144(6):1262-1272.e7. PubMed ID: 38086428
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.
Little AJ; Vesely MD
Yale J Biol Med; 2020 Mar; 93(1):81-95. PubMed ID: 32226339
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous lupus erythematosus: diagnosis and treatment.
Okon LG; Werth VP
Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):391-404. PubMed ID: 24238695
[TBL] [Abstract][Full Text] [Related]
5. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa.
Sarkar MK; Hile GA; Tsoi LC; Xing X; Liu J; Liang Y; Berthier CC; Swindell WR; Patrick MT; Shao S; Tsou PS; Uppala R; Beamer MA; Srivastava A; Bielas SL; Harms PW; Getsios S; Elder JT; Voorhees JJ; Gudjonsson JE; Kahlenberg JM
Ann Rheum Dis; 2018 Nov; 77(11):1653-1664. PubMed ID: 30021804
[TBL] [Abstract][Full Text] [Related]
6. Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis.
Garelli CJ; Refat MA; Nanaware PP; Ramirez-Ortiz ZG; Rashighi M; Richmond JM
Front Immunol; 2020; 11():1353. PubMed ID: 32714331
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus.
Englert KA; Dyduch G; Kłosowicz A; Spałkowska M; Jaworek AK; Migacz-Gruszka K; Jarosz-Chudek A; Mercuri SR; Szpor J; Mazzoccoli G; Damiani G; Wojas-Pelc A
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004071
[No Abstract] [Full Text] [Related]
8. Recent advances in cutaneous lupus.
Maz MP; Martens JWS; Hannoudi A; Reddy AL; Hile GA; Kahlenberg JM
J Autoimmun; 2022 Oct; 132():102865. PubMed ID: 35858957
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous lupus erythematosus in dogs: a comprehensive review.
Olivry T; Linder KE; Banovic F
BMC Vet Res; 2018 Apr; 14(1):132. PubMed ID: 29669547
[TBL] [Abstract][Full Text] [Related]
10. Role of neutrophils in cutaneous lupus erythematosus.
Yamamoto T
J Dermatol; 2024 Feb; 51(2):180-184. PubMed ID: 38009863
[TBL] [Abstract][Full Text] [Related]
11. Lupus Erythematosus Tumidus as a Distinct Uncommon Subtype of Cutaneous Lupus Erythematosus: A Case Report and Review.
Camisa C; Papavero V
Cureus; 2024 Apr; 16(4):e59140. PubMed ID: 38803774
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupus erythematosus.
Masek-Hammerman K; Peeva E; Ahmad A; Menon S; Afsharvand M; Peng Qu R; Cheng JB; Syed J; Zhan Y; O'Neil SP; Pleasic-Williams S; Cox LA; Beidler D
Clin Exp Immunol; 2016 Feb; 183(2):258-70. PubMed ID: 26376111
[TBL] [Abstract][Full Text] [Related]
13. The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review.
Fijałkowska A; Kądziela M; Żebrowska A
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673692
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous Lupus Erythematosus: Review and Considerations for Older Populations.
Heinly B; Allenzara A; Helm M; Foulke GT
Drugs Aging; 2024 Jan; 41(1):31-43. PubMed ID: 37991658
[TBL] [Abstract][Full Text] [Related]
15. Emerging immunotherapeutic strategies for cutaneous lupus erythematosus: an overview of recent phase 2 and 3 clinical trials.
Lim D; Kleitsch J; Werth VP
Expert Opin Emerg Drugs; 2023 Dec; 28(4):257-273. PubMed ID: 37860982
[TBL] [Abstract][Full Text] [Related]
16. Familial cutaneous lupus erythematosus (CLE) in the German shorthaired pointer maps to CFA18, a canine orthologue to human CLE.
Wang P; Zangerl B; Werner P; Mauldin EA; Casal ML
Immunogenetics; 2011 Apr; 63(4):197-207. PubMed ID: 21132284
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cutaneous lupus erythematosus: current approaches and future strategies.
Shi H; Gudjonsson JE; Kahlenberg JM
Curr Opin Rheumatol; 2020 May; 32(3):208-214. PubMed ID: 32141953
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
